The Japanese Biochemical Society/The Molecular Biology Society of Japan

ConBio2017

ConBio2017

Dec 6, 2017 - Dec 9, 2017
Kobe Port Island(Kobe International Conference Center, Kobe Portopia Hotel, Kobe International Exhibition Hall, The Kobe Chamber of Commerce and Industry)

[3P-0996] The novel selective and oral Spleen Tyrosine Kinase inhibitor, TAS05567, demonstrates efficacy in models of autoimmune diseases

〇Hiroaki Hayashi1, Shunsuke Demizu1, Ryusuke Kaneko1, Daichi Akasaka1, Hiroki Irie1, Aki Kawagishi1, Yoshio Ogino1, Teruhiro Utsugi1, Eiji Sasaki1, Yoshikazu Iwasawa1 (1.Taiho Pharmaceutical Co., Ltd.)

syk、inhibitor、autoimmune disease、animal model

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password